Feb 28, 2024 4:05 pm EST Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results Read More
Feb 26, 2024 4:05 pm EST Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche Read More
Feb 26, 2024 8:05 am EST Codexis to Participate in TD Cowen 44th Annual Health Care Conference Read More
Feb 20, 2024 8:05 am EST Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board Read More
Feb 14, 2024 4:05 pm EST Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28 Read More
Feb 13, 2024 4:05 pm EST Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones Read More
Feb 1, 2024 4:05 pm EST seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting Read More